Decreased anti-Mllerian hormone and altered ovarian follicular cohort in infertile patients with mild/minimal endometriosis
GLOW KLOW Components BPC-157, TB-500, GHK-Cu BPC-157, TB-500, GHK-Cu, KPV Peptide count 3 4 Common vial size 70 mg 80 mg Typical label split GHK-Cu 50mg / BPC-157 10mg / TB-500 10mg GHK-Cu 50mg / BPC-157 10mg / TB-500 10mg / KPV 10mg Distinguishing component KPV, the C-terminal tripeptide of alpha-MSH, studied for anti-inflammatory activity In other words, KLOW is GLOW plus KPV
BPC-157 hat keine EMA-Zulassung und ist nicht als Arzneimittel verschreibbar
Nervous system: Studies have shown support for neurite outgrowth and nerve repair
Further, it inhibits 4-hydroxynoneal, a molecule produced in the body that negatively impacts cellular growth